Preventing lung cancer by stopping smoking (Q34569416)

3 August 2017

1 reference

title

Preventing lung cancer by stopping smoking (English)

1 reference

3 August 2017

Richard D Hurt

1

1 reference

3 August 2017

Jon O Ebbert

series ordinal

2

1 reference

3 August 2017

publication date

1 March 2002

1 reference

Clinics in Chest Medicine

3 August 2017

published in

1 reference

3 August 2017

volume

23

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

27-36, vii

1 reference

Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Effects of transdermal nicotine treatment on structure and function of coronary artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Physician Referrals for Smoking Cessation: Outcome in Those Who Show and Don′t Show

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Residential (inpatient) treatment compared with outpatient treatment for nicotine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Higher levels of nicotine in arterial than in venous blood after cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Treatment of nicotine dependence. Is more better?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Are higher doses of nicotine replacement more effective for smoking cessation?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Serum nicotine and cotinine levels during nicotine-patch therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Prying Open the Door to the Tobacco Industry's Secrets About Nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Is there a common etiology for the rising incidence of and decreasing survival with adenocarcinoma of the lung?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Varying nicotine patch dose and type of smoking cessation counseling

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Smokers' misperceptions of light and ultra-light cigarettes may keep them smoking.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Site of nicotine absorption from a vapour inhaler--comparison with cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Actual causes of death in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Stages and processes of self-change of smoking: toward an integrative model of change

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Clinical use of nicotine chewing-gum.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Nicotine nasal spray and vapor inhaler: abuse liability assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Randomised controlled trial of nasal nicotine spray in smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

Tobacco withdrawal and nicotine replacement influence objective measures of sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900074-1

7 January 2021

10.1016/S0272-5231(03)00074-1

Identifiers

DOI

1 reference

3 August 2017

1 reference